Axil Capital
Tokyo, Tokyoaxilcapital.com
Overview
Axil Capital is a venture capital firm based in Tokyo, Japan, that was spun out of Mizuho Securities in 2017. It specializes in investments in the biomedical and healthcare technology sectors, investing across all stages from seed to crossover rounds. The firm invests globally in areas including biopharmaceuticals, platform technologies, medical devices, and digital health.
Portfolio Companies
8
Website
axilcapital.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Fore Biotherapeutics | Jul 2026 | Series D-2 Extension | Co-investor |
| Pulmotect | Sep 2024 | Series C | Co-investor |
| Cranebio Co., Ltd. | Oct 2023 | Series A | Co-investor |
| TechsoMed | Mar 2021 | Series B | Lead |
| Jolly Good Inc. | Jan 2021 | Series C | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
